Jazz Pharmaceuticals plc announced that the Jazz Board of Directors has unanimously selected Renee Gala, Jazz's President and Chief Operating Officer, as the President and Chief Executive Officer, effective August 11, 2025, when she will also join the Board. She will succeed co-founder, Chairperson and CEO Bruce Cozad…
HiLabs, a leading AI company solving persistent data challenges for U.S. healthcare payers, announced the appointment of Robert L. Renzi as Chief Growth Officer. With over three decades of leadership experience in healthcare technology, payer solutions, and strategic growth, Rob will lead HiLabs' go-to-market strategy…
Tellihealth, a category leader in Remote Patient Monitoring (RPM) and Chronic Care Management (CCM), has strengthened its leadership team with three key executive hires—positioning the company for its next phase of rapid, people-first growth. Joining Tellihealth are: Jill Langenfeld, Chief Operating Officer (COO)L…
BD, a leading global medical technology company, announced that, effective 2 July 2025, Bilal Muhsin has been named executive vice president and will become the president of BD's future Connected Care segment, as part of the company's previously announced plans to update its structure as it advances its New BD strateg…
Bluebird bio, a pioneer in gene therapies for severe genetic diseases, announced the appointment of Brian Riley as President and Chief Technical Officer, Joanne Lager, MD as Chief Medical Officer, and Adrian Chaisson as Chief of Staff, further bolstering its deeply experienced management team. “I am thrilled to welco…
Zynex, Inc., an innovative medical technology company specializing in noninvasive medical devices for pain management, rehabilitation, and patient monitoring, announced the appointment of Steven Dyson as Chief Executive Officer. His employment will begin on August 18, 2025. Thomas Sandgaard, Founder of Zynex and Chai…
Danaher Corporation a leading global life sciences and diagnostics innovator, announced that Greg Milosevich has been appointed by its Board of Directors to be Executive Vice President of Danaher with responsibility for its Life Sciences business, effective July 1, 2025. Mr. Milosevich has served as Vice President an…
Sun Pharmaceutical Industries Limited announced the appointment of Richard Ascroft as its new North America Chief Executive Officer (CEO), effective June 16, 2025. Richard brings over three decades of experience in the pharmaceutical industry, with a proven record of leadership, innovation, and strategic growth. As N…
BayCare Health System announced that C. Todd Jones, chief ambulatory services officer, is stepping into an expanded role. Starting immediately, Jones will also lead the not-for-profit's strategic efforts and have the dual title of chief strategy officer and chief ambulatory services officer. In his expanded role, Jon…
Axio BioPharma Inc., a next-generation biomanufacturing company using AI to transform mammalian protein production, announced the continued expansion of its advisory board with the recent addition of Patrick Haffey. He joins existing advisors Dr. Greg Bleck and Dr. Graham Brearley, forming a deeply experienced group o…
Page 10 of 14